Drugs and Devices

January 2017 Vol. 12 No. 1

The Annals of Internal Medicine has published a new guideline on the pharmacologic treatment of hypertension in adults 60 years or older and target blood pressure goals. Read more . . .

January 2017 Vol. 12 No. 1

An article in The Gerontologist discusses the implications of the rising use of cannabis in older Americans. Read more . . .

December 2016 Vol. 11 No. 12

On Dec. 20, the Food and Drug Administration (FDA) expanded the approved use of Dexcom’s G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose testing for diabetes treatment decisions in people 2 years of age and older with diabetes. Read more . . .

December 2016 Vol. 11 No. 12

On Dec. 19, the Food and Drug Administration (FDA) approved Rubraca (rucaparib) to treat women with advanced ovarian cancer who have been treated with two or more chemotherapies and whose tumors have the gene mutation deleterious BRCA as identified by an FDA-approved companion diagnostic test. Read more . . .

December 2016 Vol. 11 No. 12

On Dec. 14, the Food and Drug Administration (FDA) approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema in patients 2 years of age and older. Read more . . .

December 2016 Vol. 11 No. 12

On Dec. 7, the Food and Drug Administration (FDA) issued a guidance document stating it does not intend to enforce the requirement that individuals 18 and up receive a medical evaluation or sign a waiver before purchasing most hearing aids and announced it will consider creating a category of over . . .

October 2016 Vol. 11 No. 10

On Oct. 28, the Food and Drug Administration (FDA) approved the Amplatzer PFO Occluder device, which reduces the risk of a stroke in patients who previously had a stroke believed to be caused by a blood clot passing through a patent foramen ovale and then travelling to the brain. Read . . .